Skip to main content

Year: 2022

ATARI: HALF-YEAR 2022/2023 RESULTS

HALF-YEAR 2022/2023 RESULTSCONTINUED TRANSFORMATION EFFORTS STRATEGIC REPOSITIONING OF ALL FOUR LINES OF BUSINESSTENDER OFFER PROJECT FROM IRATA PARIS, FRANCE (December 16, 2022 – 6.00 pm CET) – Atari® — one of the world’s most iconic consumer brands and interactive entertainment producers — is announcing its consolidated financial results for the half year ended September 30, 2022. The half-year financial statements were the subject of a limited review by its Statutory Auditors. The half-year financial report is available on Atari’s investors relation website https://atari-investisseurs.fr/en/. Highlights of the first-half ended September 30, 2022Completion of a €12.5M capital increase Termination of the license related to the ATRI Token Launch of Atari X, consolidating Atari Web3 interests into a unified operation Transfer...

Continue reading

SIRIOS: Results from the Annual and Special Meeting of Shareholders

MONTREAL, Dec. 16, 2022 (GLOBE NEWSWIRE) — SIRIOS RESOURCES INC. (TSX-V: SOI) announces that all the resolutions that were presented at the annual and special meeting yesterday were approved by the shareholders. These resolutions include the appointment of the directors and the auditors as well as the renewal of the Stock Option Plan. Shareholders elected Luc Cloutier, François Auclair, Guy Le Bel, Dominique Doucet and Colinda Parent to the Board of Directors with an approval rating between 97.6 % to 98.4 %. More than 30% of the shareholders voted on the resolutions presented. Moreover, during the Board meeting held after the meeting, Mr. Frederic Sahyouni was re-elected as Chief Financial Officer and Secretary of the Company while Mr. Dominique Doucet and Luc Cloutier were re-elected as President and Chief Executive Officer, and...

Continue reading

DEINOVE – Update on the Receivership Proceedings

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and exploitation of bacterial biodiversity to address the urgent, global challenge of antibiotic resistance, announces that, in the context of the receivership proceedings (“procédure de redressement judiciaire”) opened on November 7, 2022, the Montpellier Commercial Court has met on December 16, 2022, and postponed the examination of the case to January 13, 2023. The continuation of the observation period (“période d’observation”) was requested by the bodies of the proceedings and the company DEINOVE. In the context of the implementation of disposal proceedings, the deadline for the submission of bids to the court-appointed receiver (“administrateur judiciaire”) has been set for January 9, 2023, at noon. Press releases will continue to be...

Continue reading

Innofactor Plc: Share Repurchase 16.12.2022

Innofactor Plc Announcement 16.12.2022          Innofactor Plc: Share Repurchase 16.12.2022       In the Helsinki Stock Exchange         Trade date 16.12.2022  Bourse trade Buy  Share IFA1V  Amount 9,000 SharesAverage price/ share 1.0300 EURTotal cost 9,270.00 EUR          Innofactor Plc now holds a total of 1 118 045 sharesincluding the shares repurchased on 16.12.2022          On behalf of Innofactor Plc         Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       Additional information:    Sami Ensio, CEO    Innofactor Plc    Tel. +358 50 584 2029    sami.ensio@innofactor.com         www.innofactor.com       AttachmentInnofactor_16.12_trades

Continue reading

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

LAKEWOOD, Colo., Dec. 16, 2022 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2023 at approximately 8:00 A.M. Eastern time on Monday, February 6, 2023. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacturing of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Clinical Genomics, and Calibration Solutions) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. For more information about the Company,...

Continue reading

Rovio Entertainment Corporation: Repurchase of own shares on 16 December 2022

Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 16.12.2022 at 18.45 EET   Rovio Entertainment Corporation – Repurchase of own shares on 16.12.2022   Rovio Entertainment Corporation  In the Nasdaq Helsinki  Date 16.12.2022Exchange transaction BUYShare trading code ROVIOAmount, shares 24738Average price/share, EUR 5,975748Total cost, EUR 147828,07      Rovio now holds a total of 6 731 151 shares including the shares repurchased on 16.12.2022   On behalf of Rovio Entertainment Corporation     OP Corporate Bank PLC  Further information:Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution:Nasdaq Helsinki LtdKey mediawww.rovio.com About Rovio:Rovio Entertainment Corporation is a global mobile-first games company that creates,...

Continue reading

Press release Biocartis Group NV: Completion of Mandatory Conversion

PRESS RELEASE: REGULATED INFORMATION16 December 2022, 17:40 CET Completion of Mandatory Conversion Capitalized terms not otherwise defined in this notice shall have the meaning given to them in the Terms and Conditions of the Bonds. Mechelen, Belgium, 16 December 2022 – Biocartis Group NV (the “Company” or “Biocartis”), an innovative molecular diagnostics company (Euronext Brussels: BCART) announces today that, in accordance with Condition 5(m) of the terms and conditions of the Company’s 4.00% convertible bonds due 2027 (ISIN BE0002651322) (the “Existing Convertible Bonds”) and Condition 6(b) of the terms and conditions of the Company’s 4.50% new second lien secured convertible bonds due 2026 (ISIN BE6338582206) (the “New Convertible Bonds”, and together with the Existing Convertible...

Continue reading

Energem Corp. Deposits Extension Funds in Trust Account

Kuala Lumpur, Malaysia, Dec. 16, 2022 (GLOBE NEWSWIRE) — Energem Corp. (“Energem” or the “Company”) (Nasdaq: ENCP, ENCPW), a special purpose acquisition company, today announced the payment of approximately $85,296.45 to its Trust Account (as defined herein) in connection with the second monthly extension of the Termination Date (as defined herein). On November 18, 2021, the Company consummated its initial public offering (the “IPO”). In connection therewith, the Company entered into an Investment Management Trust Agreement, dated November 18, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (“Continental”) (the “Trust Agreement”). A form of the Trust Agreement was initially filed as an exhibit to the Company’s Registration Statement on Form S-1 (File No. 333-259443) in connection...

Continue reading

Chalice Brands Reports Select Preliminary Unaudited Fiscal Year End 2021 Results and 2021 Operational Update

PORTLAND, Ore., Dec. 16, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (the “Company” or “Chalice Brands”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announces select preliminary unaudited financial results for the year ended December 31, 2021. All financial information is provided in U.S. dollars unless otherwise indicated. “We acknowledge the internal and external challenges that have resulted in our delay in issuing audited financial statements have been frustrating for all of our stakeholders,” commented Jeff Yapp, President and Chief Executive Officer. “We expect the audited 2021 financial results to be filed imminently, followed by the subsequent quarterly results for 2022. We will remain under the Cease Trade Order...

Continue reading

CORRECTION – Caldwell Investment Management Announces Special Distribution for Caldwell U.S. Dividend Advantage Fund ETF

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 16, 2022 (GLOBE NEWSWIRE) — Caldwell Investment Management Ltd., the manager of Caldwell U.S. Dividend Advantage Fund (the “Fund”) states that on Dec 15, 2022, the Fund disseminated a news release announcing a distribution of $0.11 per unit to unitholders of record on Dec 21, 2022. The distribution rate of the distribution was incorrectly shown as $0.11 per unit in that news release. The correct distribution rate is $0.1264716. All other information in that news release, including the record date of Dec 21, 2022 and payment date of Dec 23, 2022, remains the same. The ETF Series of Caldwell U.S. Dividend Advantage Fund trades on the TSX under the ticker symbol UDA. For further information, please visit our website at www.caldwellinvestment.com...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.